✦ LIBER ✦

Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping

✍ Scribed by Filippo Ansaldi; Francesco Torre; Bianca Marisa Bruzzone; Antonino Picciotto; Pietro Crovari; Giancarlo Icardi

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 97 KB
Volume: 63
Category: Article
ISSN: 0146-6615
DOI: 10.1002/1096-9071(200101)63:1<17::aid-jmv1002>3.0.co;2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of two simplified methods for

Evaluation of two simplified methods for genotyping hepatitis C virus

✍ Khan, R. U.; Tong, C. Y. W.; Bloom, S.; Gilmore, I. T.; Toh, C. H.; Bolton-Maggs 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 998 KB

A number of different approaches have been used for genotyping hepatitis C virus (HCV). Two simplified methods were evaluated, both of which used polymerase chain reaction (PCR) to amplify products from the 5Ј non-coding region of HCV: non-isotopic restriction fragment length polymorphism (RFLP) ana

Development of a TaqMan assay for the si

Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays

✍ Ronald E. Engle; Rodney S. Russell; Robert H. Purcell; Jens Bukh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

## Abstract A quantitative real‐time PCR assay was developed that detects genomic RNA from reference strains representing the six major genotypes of hepatitis C virus (HCV) with equal sensitivity and accurately measured HCV RNA in JFH1 HCV‐infected Huh7.5 cells. The method is indirectly calibrated

Evaluation of a total core antigen assay

Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients

✍ N. Bouzgarrou; I. Fodha; S. Ben Othman; A. Achour; F. Grattard; A. Trabelsi; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

Hemodialysis patients are recognized as a group at high risk of infection with hepatitis C virus (HCV). Therefore, such a population should be screened routinely for the presence of HCV viremia. Since nucleic acid techniques remain expensive and largely unavailable in many laboratories in the develo

Evaluation of a total hepatitis C virus

Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals

✍ Pierpaolo Valcavi; Maria Cristina Medici; Francesca Casula; Maria Cristina Arcan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

## Abstract A new, sensitive enzyme immunoassay has been developed for detecting and quantifying total hepatitis C virus (HCV) core antigen in anti‐HCV positive or negative sera (“__trak__‐__C__™”, Ortho Clinical Diagnostics, Raritan, NJ). The purpose of this study was to evaluate the performance o

Case-control study on hepatitis C virus

Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: The role of HCV genotypes and the synergism with hepatitis B virus and alcohol

✍ Alessandro Tagger; Francesco Donato; Maria L. Ribero; Roberta Chiesa; Giuseppe P 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 70 KB 👁 3 views

We performed a case-control study to evaluate the risk of hepatocellular carcinoma (HCC) for hepatitis C virus (HCV) infection. A total of 305 newly diagnosed HCC cases (80% males) and 610 subjects (81% males) unaffected by clinically evident hepatic disease admitted to the 2 main hospitals in Bresc

Prospective assessment of donor blood sc

Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis

✍ S Takano; K Nakamura; S Kawai; O Yokosuka; Y Satomura; M Omata 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

In November 1989, the Japanese Red Cross began transfusion. [4][5][6] In December 1989, first-generation hepscreening blood donors for the hepatitis C virus antiatitis C virus antibodies (anti-HCV) to detect the antibody (anti-HCV) by first-generation assay and high-titer body against nonstructural